NBL1 Correlates with Kidney Disease in a Mouse Model for Alport Syndrome, but Is Not Causal

被引：0
|
作者：
Willey, Courtney [1 ,2 ]
Bufi, Rei [1 ]
Brackett, Abigail [1 ]
Sheehan, Susan Marie [1 ]
Korstanje, Ron [1 ,2 ]
机构：
[1] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
[2] Univ Maine, Orono, ME USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024rg098x15
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO613
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Testing the Relationship Between NBL1 and CKD in a Cisplatin-Induced Mouse Model
    Bufi, Rei
    Sheehan, Susan M.
    Korstanje, Ron
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 595 - 595
  • [2] Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome
    Ning, Liang
    Suleiman, Hani Y.
    Miner, Jeffrey H.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 321 (01) : F12 - F25
  • [3] Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome
    Tanaka, Mari
    Asada, Misako
    Higashi, Atsuko Y.
    Nakamura, Jin
    Oguchi, Akiko
    Tomita, Mayumi
    Yamada, Sachiko
    Asada, Nariaki
    Takase, Masayuki
    Okuda, Tomohiko
    Kawachi, Hiroshi
    Economides, Aris N.
    Robertson, Elizabeth
    Takahashi, Satoru
    Sakurai, Takeshi
    Goldschmeding, Roel
    Muso, Eri
    Fukatsu, Atsushi
    Kita, Toru
    Yanagita, Motoko
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (03): : 768 - 777
  • [4] Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
    Matsumura, Takuma
    Terada, Jiro
    Kinoshita, Taku
    Sakurai, Yoriko
    Yahaba, Misuzu
    Tsushima, Kenji
    Sakao, Seiichiro
    Tatsumi, Koichiro
    Kunii, Reiko
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [5] Opposite function of matrix metalloproteinases in initiation and progression of kidney disease in a mouse model for Alport syndrome.
    Zeisberg, M
    Hamano, Y
    Khurana, M
    Werb, Z
    Kalluri, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 586A - 587A
  • [6] Farnesoid X Receptor Agonist Obeticholic Acid Reduces Kidney Disease in a Mouse Model of Alport Syndrome
    Jones, Bryce A.
    Perry, Priscilla E.
    Davidson, Shania R.
    Santiago, Isabel Lopez
    Adapa, Sharmila
    Allen, Katherine C.
    Dial, Katelyn
    Rowland, Emma
    Myakala, Komuraiah
    Wang, Xiaoxin
    Levi, Moshe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 511 - 511
  • [7] Protective effects of p53 in a mouse model of progressive hereditary kidney disease Alport syndrome
    Fukuda, R.
    Koyama, K.
    Koga, T.
    Kai, Y.
    Suico, M. A.
    Shuto, T.
    Kai, H.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [8] Alport syndrome and Alport kidney diseases - elucidating the disease spectrum
    Puapatanakul, Pongpratch
    Miner, Jeffrey H.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (03): : 283 - 290
  • [9] APOM Deficiency Affects Kidney Function in an Experimental Mouse Model of Alport Syndrome
    David, Molina Judith T.
    Tolerico, Matthew
    Kim, Jin Ju
    Fontanella, Antonio Miguel
    Carrazco, Arianna
    Merscher, Sandra M.
    Fornoni, Alessia
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [10] A NOVEL KNOCKIN MOUSE MODEL FOR ALPORT SYNDROME
    Savva, Isavella
    Stefanou, Charalampos
    Pieri, Myrtani
    Borza, Dorin B.
    Stylianou, Kostas
    Lapathitis, George
    Karaiskos, Christos
    Papagregoriou, Gregoris
    Deltas, Constantinos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 354 - 354
12345